Results 101 to 110 of about 29,949 (204)

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin

open access: yes, 2016
Background: The Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism (RECORD) 1 to 4 trials compared rivaroxaban 10 mg daily with commonly used doses of enoxaparin and demonstrated similar rates of VTE ...
El-Bazouni, Hadi   +7 more
core   +1 more source

Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes

open access: yesHaematologica, 2001
BACKGROUND AND OBJECTIVES: Unfractionated heparin (UFH) and enoxaparin (low molecular weight heparin) constitute fundamental therapies in the treatment of patients with acute coronary syndrome (ACS).
V Vila   +6 more
doaj  

NMR assignments of enoxaparin disaccharide.

open access: yes, 2015
Atoms in the glucosamine unit are denoted by the prime superscript.Cq (COO-) 169.1 ppm, C6 (Ido) 144.79 ppm.NMR assignments of enoxaparin disaccharide.
Madhur D. Shastri (698427)   +6 more
core   +1 more source

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study

open access: yesJournal of Research in Pharmacy Practice
Objective: Anticoagulation therapy, including enoxaparin, is crucial for preventing blood clots in patients at risk for thromboembolic events. However, due to enoxaparin’s enhanced renal elimination, proper prophylactic dosing may be challenging.
Zahra Sahraei   +2 more
doaj   +1 more source

Anticoagulant profile of subcutaneous enoxaparin in healthy dogs [PDF]

open access: yes, 2020
Enoxaparin, a low-molecular-weight heparin, is commonly used as an anticoagulant in dogs, and is currently dosed at 0.8mg/kg every 6 hours. With an increase in individual enoxaparin doses, less frequent dosing may be possible, thereby reducing owner ...
Frum, Julianna
core  

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

open access: yes, 2008
BACKGROUND: We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty.
RECORD3 Investigators   +12 more
core   +1 more source

Bullous hemorrhagic dermatosis induced by enoxaparin

open access: yes, 2015
© 2015 Informa Healthcare USA, Inc.The bullous hemorrhagic dermatosis induced by enoxaparin is a rare adverse reaction, which may be under-reported given its favorable evolution.
Soares-de-Almeida, Luís   +3 more
core   +1 more source

Economic impact of enoxaparin after acute ischemic stroke based on PREVAIL

open access: yes, 2010
The efficacy and safety of low-molecular-weight heparins (LMWHs) versus unfractionated heparin (UFH) has been demonstrated for the prevention of venous thromboembolism (VTE) after acute ischemic stroke.
Pineo, Graham   +9 more
core   +1 more source

Enoxaparin pretreatment alleviates pentylenetetrazol–induced epileptic seizures in Wistar rats

open access: yesRevista Científica
Epilepsy, is a prevalent neurological disorder characterized by recurring seizures. A low molecular weight heparin enoxaparin has multifaceted properties.
Huseyin Gungor, Nergiz Hacer Turgut
doaj   +1 more source

A comparison of enoxaparin and tinzaparin’s relative effects on aPTT.

open access: yes, 2015
Bland-Altman plot showing that the aPTT’s induced by tinzaparin ranged from on average 49% more than enoxaparin (when measured using the PTT-Automat reagent) to 66% more than enoxaparin (when measured using the MRX931 reagent (FOR: free oscillation ...
Owain Thomas (597280)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy